Clinical effect of obinutuzumab in the treatment of idiopathic membranous nephropathy
American Journal of Translational Research · 2026 · 18 (6) · 4777-4790
DOI: 10.62347/hhhf9971 ↗At a glance
Journal article in American Journal of Translational Research, 2026. Written by Shaoxiong Ning and 3 co-authors. Institution: Department of Nephrology, Yuncheng Central Hospital Yuncheng 044000, Shanxi, China. The full text is freely available in PubMed Central.
Abstract (original language)
Není k dispozici žádný abstrakt.
Subjects
Author keywords
Authors and institutions
- Department of Nephrology, Yuncheng Central Hospital Yuncheng 044000, Shanxi, China.
- Department of Cardiology, Yuncheng Central Hospital Yuncheng 044000, Shanxi, China.
Cite
APA
Ning, S., Zhang, Q., Shang, Z., & Liu, H. (2026). Clinical effect of obinutuzumab in the treatment of idiopathic membranous nephropathy. American Journal of Translational Research, 18(6), 4777-4790. https://doi.org/10.62347/hhhf9971
Vancouver
Ning S, Zhang Q, Shang Z, Liu H. Clinical effect of obinutuzumab in the treatment of idiopathic membranous nephropathy. American Journal of Translational Research. 2026;18(6):4777-4790. doi:10.62347/hhhf9971
BibTeX
@article{Ning2026,
author = {Ning, Shaoxiong and Zhang, Qian and Shang, Zhixing and Liu, Hongting},
title = {Clinical effect of obinutuzumab in the treatment of idiopathic membranous nephropathy},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {6},
pages = {4777--4790},
doi = {10.62347/hhhf9971}
}
EUVIMED